期刊文献+

Regulation of TAZ in cancer 被引量:5

Regulation of TAZ in cancer
原文传递
导出
摘要 TAZ, a transcriptional coactivator with PDZ-binding motif, is encoded by WWTR1 gene (WW domain containing transcription regulator 1). TAZ is tightly regulated in the hippo pathway-dependent and -independent manner in response to a wide range of extracellular and intrinsic signals, including cell density, cell polarity, F-actin related mechanical stress, ligands of G protein-coupled recep- tors (GPCRs), cellular energy status, hypoxia and osmo- tic stress. Besides its role in normal tissue development, TAZ plays critical roles in cell proliferation, differentiation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT), and stemness in multiple human cancers. We discuss here the regulators and regulation of TAT. We also highlight the tumorigenic roles of TAZ. and its potential therapeutic impact in human cancers. TAZ, a transcriptional coactivator with PDZ-binding motif, is encoded by WWTR1 gene (WW domain containing transcription regulator 1). TAZ is tightly regulated in the hippo pathway-dependent and -independent manner in response to a wide range of extracellular and intrinsic signals, including cell density, cell polarity, F-actin related mechanical stress, ligands of G protein-coupled recep- tors (GPCRs), cellular energy status, hypoxia and osmo- tic stress. Besides its role in normal tissue development, TAZ plays critical roles in cell proliferation, differentiation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT), and stemness in multiple human cancers. We discuss here the regulators and regulation of TAT. We also highlight the tumorigenic roles of TAZ. and its potential therapeutic impact in human cancers.
出处 《Protein & Cell》 SCIE CAS CSCD 2016年第8期548-561,共14页 蛋白质与细胞(英文版)
关键词 TAZ the Hippo pathway CANCER TAZ, the Hippo pathway, cancer
  • 相关文献

参考文献3

二级参考文献67

  • 1Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010, 19: 491-505.
  • 2Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human can?cer. Nat Rev Cancer 2013, 13: 246-257.
  • 3Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size con?trol and tumorigenesis: an updated version. Genes Deu 2010, 24: 862-874.
  • 4Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Deu 2013, 27: 355-371.
  • 5Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, et al. TAZ pro?motes cell proliferation and epithelial-mesenchymal transition and is inhib?ited by the Hippo pathway. Mol Cell Bioi 2008, 28: 2426-2436.
  • 6Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhib?ition and tissue growth control. Genes Deu 20P7, 21: 2747-2761.
  • 7Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130: 1120-1133.
  • 8Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATSI is a negative regulator of oncogene YAP. J Bioi Chem 2008, 283: 5496-5509.
  • 9Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphor?ylation by Lats and CKI regulates YAP stability through SCF (beta-TRCP). Genes Dev 2010, 24: 72-85.
  • 10Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, et al. The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFfbetaJ-TrCP E3 ligase. J Bioi Chern 2010,285: 37159-37169.

共引文献17

同被引文献23

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部